0001103021-22-000019.txt : 20220131
0001103021-22-000019.hdr.sgml : 20220131
20220131175957
ACCESSION NUMBER: 0001103021-22-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220127
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Golubieski John
CENTRAL INDEX KEY: 0001610695
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 22575859
MAIL ADDRESS:
STREET 1: C/O LANTHEUS HOLDINGS, INC.
STREET 2: 331 TREBLE COVE ROAD
CITY: NORTH BILLERICA
STATE: NY
ZIP: 01862
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_164366997243576.xml
FORM 4
X0306
4
2022-01-27
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001610695
Golubieski John
4131 PARKLAKE AVENUE
SUITE 225
RALEIGH
NC
27612
0
1
0
0
See Remarks
Stock Options (right to buy)
3.66
2022-01-27
4
A
0
373533
3.66
A
2032-01-26
Common Stock
373533.0
373533
D
Restricted Stock Units
0.0
2022-01-27
4
A
0
66940
0
A
2025-01-27
Common Stock
66940.0
66940
D
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
Chief Financial Officer and Treasurer
John Golubieski
2022-01-31